Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Veronique Van De Velde

Ghent University Hospital

Work address: PHO - Pediatrische hemato-oncologie C. Heymanslaan 10
9000 Gent
Email: VERONIQUE.VANDEVELDE@UGent.be

Show Sort by

Mark
- conference
- C3
- open access
Procedure of informed assent/consent for clinical trials in pediatric hemato-oncology: the adelescents' and parent's point of view

Veronique Van De Velde (UGent) , E De Strooper, Ann Morez (UGent) , N Van Broeck, Genevieve Laureys (UGent) , Yves Benoit (UGent) and Catharina Dhooge (UGent)

(2013) PEDIATRIC BLOOD & CANCER. 60(suppl. 3). p.38-39
Mark
Off-label and unlicensed use in a pediatric hemato-oncology unit

Tieneke Bauters (UGent) , Barbara De Moerloose (UGent) , Veronique Van De Velde (UGent) , Myriam Van Winckel (UGent) , Hugo Robays (UGent) , Yves Benoit (UGent) and JORIS VERLOOY (UGent)

(2011) PEDIATRIC BLOOD & CANCER. 57(5). p.731-731
Mark
- misc
Practical implications for the administration of 13-cis retinoic acid in pediatric oncology

Tieneke Bauters (UGent) , Veronique Van De Velde (UGent) , Yves Benoit (UGent) , Hugo Robays (UGent) and Genevieve Laureys (UGent)

(2011) INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. 33(4). p.597-598
Mark
- conference
- C3
Weblogs of parents with a child treated for cancer: their intentions and experiences

Veronique Van De Velde (UGent) , Ilse Demares, Patricia De Vos (UGent) , JOHAN DE PORRE (UGent) , Barbara De Moerloose (UGent) , Yves Benoit (UGent) and Gino Verleye (UGent)

(2010) PEDIATRIC BLOOD & CANCER. 55(5). p.810-810
Mark
Highly effective treatment with tacrolimus ointment in an adolescent with oral graft-versus-host disease

Tieneke Bauters (UGent) , Maria Bordon Cueto De Braem (UGent) , Veronique Van De Velde (UGent) , Sophie Van Lancker (UGent) , Hugo Robays (UGent) , Yves Benoit (UGent) and Genevieve Laureys (UGent)

(2010) PHARMACY WORLD & SCIENCE. 32(3). p.350-352
Mark
- conference
- C3
Survey on 1.010 skin tunnelled central venous catheters (Hickman-Broviac) in 840 children in a pediatric haemat-oncology unit

JOHAN DE PORRE (UGent) , Veronique Van De Velde (UGent) , Katrien Van Renterghem (UGent) , JORIS VERLOOY (UGent) , Catharina Dhooge (UGent) and Yves Benoit (UGent)

(2009) PEDIATRIC BLOOD & CANCER. 53(5). p.894-894
Mark
- conference
- C3
CREATING A PLAY AREA AND LIVING-ROOM FOR SIBLINGS OF CANCER PATIENTS AT THE PEDIATRIC HEMATO-ONCOLOGY UNIT

Ann Morez (UGent) , JOHAN DE PORRE (UGent) , Veronique Van De Velde (UGent) , Maria Bordon Cueto De Braem (UGent) , Patricia De Vos (UGent) and Yves Benoit (UGent)

(2009) PEDIATRIC BLOOD & CANCER. 53(5). p.874-874
Mark
- conference
- C3
Chemotherapy medication error rate in a pediatric hemato-oncology department

Veronique Van De Velde (UGent) , Tieneke Bauters (UGent) , Johan Vandenbroucke (UGent) , JOHAN DE PORRE (UGent) , Hugo Robays (UGent) , JORIS VERLOOY (UGent) and Genevieve Laureys (UGent)

(2009) PEDIATRIC BLOOD & CANCER. 53(5). p.743-743
Mark
- misc
Prevention of wrong route errors in a pediatric hemato-oncology ward

Tieneke Bauters (UGent) , JOHAN DE PORRE (UGent) , Nicky Janssens (UGent) , Veronique Van De Velde (UGent) , JORIS VERLOOY (UGent) , Catharina Dhooge (UGent) and Hugo Robays (UGent)

(2009) PHARMACY WORLD & SCIENCE. 31(5). p.522-524
Mark
- conference
- C3
Reducing the risk of wrong route errors by using oral liquid dispensers

Tieneke Bauters (UGent) , JOHAN DE PORRE (UGent) , Nicky Janssens (UGent) , Veronique Van De Velde (UGent) , JORIS VERLOOY (UGent) , Catharina Dhooge (UGent) and Hugo Robays (UGent)

(2009) PEDIATRIC BLOOD & CANCER. 53(5). p.893-893

1
2

Next →